OBJECTIVES: Local breast cancer recurrence is often viewed as an early sign of rapidly progressive metastatic disease for which chest wall resection (CWR) can provide no benefits. We retrospectively reviewed our experience with full-thickness CWR to determine whether long-term outcomes warranted this aggressive procedure. Between 2001 and 2012, 33 women (mean age, 50.7 years; range, 33-72 years) underwent en-bloc CWR with curative intent. Mean disease-free interval from initial tumour resection was 90.5 months (range, 2-252 months). Resection included skin, muscle and an average of 2.7 ribs (range, 1-8 ribs) and was extended to the sternum (n = 21), subclavian vessels (n = 9), lung (n = 8), pericardium (n = 8), phrenic nerve (n = 2) or T1 nerve root (n = 1). Complete R0 resection was achieved in 31 (94%) patients. Chest wall reconstruction was performed in 28 patients, with polytetrafluoroethylene mesh (n = 17) or titanium ribs (n = 11). A musculocutaneous flap was used in 17 (52%) patients.
INTRODUCTION
Breast cancer is the leading cause of death by cancer in women in industrialized countries [1] . Local breast cancer recurrence is seen in 5-40% of patients after mastectomy or conservative breast therapy, depending on the risk factors and primary treatment strategy [2] . In a study of breast-conserving therapy for tumours measuring 2.1-5 cm, local recurrence developed in 11.8% of patients after 5 years and 19.7% after 10 years and was combined with distant metastases in 30% of cases [3] .
A diagnosis of local recurrence during follow-up after breast cancer treatment is often misinterpreted by oncologists as an early sign of rapidly progressive metastatic disease for which no curative treatment is available [4] [5] [6] . Furthermore, extensive chest wall resection (CWR) leaving a sufficient safety margin is usually viewed as a mutilating procedure associated with high morbidity and mortality rates [5] . Most patients with locally recurring breast cancer have already received radiation therapy, which often leads to the misconception that only palliative care is appropriate [6] . However, two-thirds of patients with local recurrences involving the chest wall have no other sites of involvement and can therefore achieve favourable outcomes [7, 8] .
Important advances in CWR techniques were achieved recently. Rib replacement is now available for improving the postoperative outcome, and also plastic surgery techniques for filling and covering large defects [9, 10] . Extensive CWR can allow the radical resection of an isolated local breast cancer recurrence. In addition, CWR relieves symptoms such as pain, local bleeding or a foul-smelling discharge, thereby improving the quality of life [6] . However, very few studies have reported long-term outcomes after extensive CWR for isolated breast cancer recurrence, a procedure with which few oncologists are familiar.
Here, our objective was to assess outcomes after extensive full-thickness CWR for isolated local breast cancer recurrence. We sought to determine whether survival and quality of life warranted this aggressive procedure. To this end, we retrospectively reviewed prospectively collected data from all patients managed at our institution over an 11-year period.
MATERIALS AND METHODS
Between June 2001 and February 2012, 33 women with isolated locally recurrent breast cancer underwent en-bloc full-thickness CWR with curative intent at the Department of Thoracic Surgery of the Marie Lannelongue Hospital, Le Plessis-Robinson, France. During this study period, 4 other patients were referred with the intent of surgical resection of an isolated recurrent breast cancer, but were contraindicated to surgery during the preoperative work-up because of the emergence of one or multiple new metastases. Our institutional review board approved this retrospective study and waived the need for informed consent.
Definitions
Isolated local recurrence was defined, in patients having received breast cancer treatment, as recurrent tumour involving the remaining glandular tissue, covering flap or ipsilateral chest wall including the lymph nodes, with histological confirmation and no distant metastases by preoperative work-up. Patients with chest wall radiation-induced sarcomas or radionecrosis were excluded. Full-thickness CWR was defined as the resection of all visible tumour, extended to the surrounding skin with a safety margin of at least 2 cm, remaining glandular tissue, involved chest muscles, and at least one rib or part of the sternum. Bone invasion was defined as pathological evidence of tumour in the rib cortex or sternum. Complete resection (R0) was defined as negative tissue margins by definitive histological assessment without any other distant lesion found during the procedure.
Preoperative work-up
The preoperative work-up consisted of a standard pulmonary and cardiac evaluation. Investigations done to evaluate disease spread included a standard chest radiograph; mammography; computed tomography (CT) of the head, neck and chest and magnetic resonance imaging (MRI) of the chest wall. Positron emission tomography was performed routinely starting in June 2005. The diagnosis was always confirmed by CT-guided needle biopsy or open surgical biopsy. Bone invasion was suspected based on permanent pain exacerbated by palpation or on MRI findings.
Surgical technique
All CWR procedures were done jointly by a thoracic surgeon and a plastic oncological surgeon. Patients were in the supine position on the operating table with a single cushion on the midline between the scapulas, allowing CWR and musculo cutaneous flap harvesting. In all patients, an attempt was made to achieve en-bloc resection removing the visible tumour, surrounding skin with a safety margin of at least 2 cm, remaining glandular tissue, involved chest muscles and bones (ribs and sternum) and adjacent structures. Frozen sections were routinely performed to ensure disease-free margins. Chestwall reconstruction followed by musculocutaneous flap covering was consistently performed during the same procedure.
Statistics
Patient data were recorded prospectively. Follow-up information and current oncological status were obtained by patient interview during clinic visits or by telephone interview with relatives, the family physician and/or the patient's oncologist. Continuous variables were described as mean and range and compared using the unpaired two-tailed t-test. Categorical variables were reported as proportion (%). Survival after surgery and diseasefree survival (DFS) were calculated from the date of CWR and analysed using the Kaplan-Meier method.
For univariate analysis, a log-rank test was performed to compare groups regarding survival estimates. Variables studied by univariate analysis were age at primary tumour resection (≤40 or >40 years), bone invasion by histology, disease-free interval (DFI) since primary breast cancer treatment (≤2 or >2 years), largest tumour diameter (≤5 or >5 cm), number of local recurrences (1 or >1), subclavian artery or vein involvement, completeness of resection (R0 or R1, 2), resection extended to adjacent structures and lymph node status. Due to the limited size of the study, multivariate analysis was not performed. All statistical analyses were run on Statview V (Abacus Concept, Berkeley, CA, USA). Values of P < 0.05 were considered significant.
RESULTS

Patients
The 33 women had a mean of 50.7 years (range, 33-72 years) at CWR. Table 1 describes the primary breast cancer treatments. A history of CWR for local recurrence was noted in 16 (48%) patients. Mean DFI was 90.5 months (range, 2-252 months). Symptoms of recurrence included pain in 31 (94%) patients, a local ulcer oozing blood in 5 (15%), and a malodorous discharge in 2 (6%). The local recurrence was the first recurrence in 17 (52%) patients, the second in 8 (24%), the third in 6 (18%), the fourth in 1 (3%) and the ninth in 1 (3%).
Chest wall resection and reconstruction
The surgical data are detailed in Table 2 . Mean operative specimen size was 138 cm 2 (range, 8-374 cm²) and mean largest diameter was 12.6 cm (range, 4-22 cm). The resection included skin, muscle and an average of 2.7 ribs (range, 0-8 ribs) and was extended to the sternum (n = 21), subclavian vessels (n = 9), phrenic nerve (n = 2), T1 nerve root (n = 1), lung (n = 8) or pericardium (n = 8). Complete sternectomy was performed in 6 (18%) patients (Fig. 1) . Subclavian artery invasion led to resection of the artery with revascularization by end-to-end anastomosis. Subclavian vein invasion was treated by vein ligation followed by oral anticoagulation for 6 months. Definitive histology showed R1 microscopic resection in 6 patients, of whom 5 underwent repeat surgery very shortly afterwards (4, 5, 5, 6 and 35 days): completion sternectomy was performed in 1 patient, further rib resection in 3 and soft tissue resection in 1. Extending the initial CWR was not deemed feasible in the remaining patient. Palliative R2 resection because of pleural carcinosis was performed in 1 patient. Thus, complete R0 resection was achieved in 31 (94%) patients. Bone involvement was found in 14 (42%) patients and lymph node involvement by recurrence in 7 (21%) patients.
Chest wall stability was restored in 28 patients, using 2 mm-thick polytetrafluoroethylene (PTFE) mesh alone (W.L. Gore & Assoc., Flagstaff, AZ, USA) in 17 (52%) patients before 2008. Subsequently, in 11 (33%) patients, we used titanium bars (Stratos, MedXpert GMH, Heitersheim, Germany and Thorib, Neuro France Implants, Boursay, France) secured to the remaining ribs and lined with polyglactin mesh (Vicryl, Ethicon, Issy Les Moulineaux, France), as previously described [9] ; one bar was required in 3 patients, two bars in 7 and three bars in 1. In the remaining 5 patients, the resection of a single rib was sufficient and did not compromise chest wall stability. To achieve skin closure, 17 (52%) patients required a pedicled musculocutaneous flap, from the latissimus dorsi (n = 16) or rectus abdominis (n = 1). In the remaining 16 patients, the pectoralis major muscles were dissected and mobilized to cover the chest wall defect and the skin was closed directly.
Adjuvant chemotherapy was given alone in 6 patients, combined with radiation therapy in 2 patients and combined with hormonal therapy in 2 patients. Two other patients received hormonal therapy alone as adjuvant treatment.
Surgery-related morbidity and mortality
There were no perioperative deaths. Postoperative complications occurred in 12 (36%) patients, of whom 10 underwent reoperation, for bleeding (n = 2), wound infection requiring PTFE mesh removal with preservation of the musculocutaneous flap (n = 5), periprosthetic seroma requiring surgical drainage (n = 1) or removal of a broken titanium bar (n = 2). The remaining 2 patients developed postoperative pneumonia requiring prolonged mechanical ventilation due to flail chest. Complication rates were not significantly different between the patients managed with titanium bars and those managed with PTFE mesh (4/11 vs 7/17; P = 0.67). Mechanical ventilation duration was <24 h in 31 (94%) patients. Median hospital stay length was 16.3 days (range, 5-52 days).
Survival
All patients were available for follow-up. Median follow-up was 33 months (range, 3-96 months) and median follow-up of (Fig. 2) . Six (18%) patients are alive and free of disease more than 5 years after CWR. By univariate analysis (Table 3) , only resection extended to intrathoracic structures (lung, vessels, nerves, pericardium) was associated with better survival (P = 0.033). Thus, 1-, 3-and 5-year survival rates were 100, 83 and 66%, respectively, in patients with extended resection, compared with 100, 67 and 44%, respectively, in patients with more limited resection (P = 0.033). During follow-up, recurrences occurred in 13 (39%) patients, including 1 with a strictly local recurrence, 5 with local and distant recurrences and 7 with distant recurrences only. The patient with a strictly local recurrence underwent repeat surgery 6 months after the CWR and was free of disease 33 months later. The 1-, 3-and 5-year DFS rates were 77, 57 and 50%, respectively (Fig. 3) . The risk factors for recurrence are listed in Table 4 .
DISCUSSION
Isolated local breast cancer recurrence occurs in a substantial proportion of patients and is often taken to indicate that curative treatment is no longer an option. Here, we found that complete en-bloc full-thickness CWR with curative intent provided a 5-year survival rate of 63%. The postoperative complication rate was 36%, with no deaths. Although several preliminary studies published before the turn of the century reported encouraging outcomes after CWR for local breast cancer recurrence [11] [12] [13] [14] [15] , to date the optimal treatment strategy has not been agreed on. Recent studies were caseseries studies in small numbers of patients (Table 5 ) [4] [5] [6] [16] [17] [18] [19] . Most oncologists believe that local breast cancer recurrence always indicates the presence of distant metastases [5] . Patients are therefore often referred to surgery only after having exhausted all other treatment options [20] . The effectiveness of radiation therapy in local breast cancer recurrences is controversial, with local control rates varying widely, from 17 to 68% [21, 22] . This variability can be ascribed to the inclusion in some studies of patients given radiation therapy after CWR [22] . Outcomes are worse when CWR is performed after failed radiation therapy for breast cancer recurrence [16] . The best use of radiation therapy seems to be adjunctive postoperative treatment after R1 CWR, a situation in which overall survival and DFS rates are then similar to those seen after R0 CWR [20] .
Strong evidence indicates that the incidence of metastases is similar after primary treatment and local recurrence treatment, with a peak after 2 years followed by a decrease, confirming that local recurrence should be considered a repeat episode of local disease and not a metastasis [23] . The requirements for the treatment of this local episode are the same as for the primary treatment: en-bloc resection must be performed, with sufficient safety margins [5] .
The most important risk factor for failure of surgical resection in local recurrences is an insufficient safety margin. Confining the resection to the soft tissues is associated with rerecurrence rates of up to 62% [21] , which are not improved by adjuvant radiation therapy [23] . Consequently, we believe that full-thickness CWR is the best option to avoid local rerecurrence. Only 6 of our 33 patients developed local recurrences after CWR, yielding a local control rate of 82%. Two main factors explain this good result. First, the close collaboration between the thoracic surgeon and plastic surgeon who performed CWR jointly allowed very extensive soft tissue resection, thereby ensuring sufficient free margins. In particular, the use of pedicled or free musculocutaneous flaps to cover the chest wall defect constitutes a major improvement. Second, improvements in the material used for chest wall reconstruction have led to better chest wall stability with less risk of flail chest and respiratory failure. The implantation of titanium bars to restore chest wall rigidity decreases the risk of respiratory failure, prolonged mechanical ventilation and pneumonia [9] , which are the most serious complications following full-thickness CWR, together with wound infections. The improvement in chest wall stability explains the postoperative mortality rates being no greater than 2% in recent studies and the absence of postoperative deaths in our study [4, 5, 19] . The availability of titanium-bar reconstruction also allows both the resection of larger amounts of bone and the use of fullthickness CWR in patients previously considered ineligible for this procedure because of lung function impairment [9] . The 36% morbidity rate in the present study is within the previously reported range of 20-50% [5, 16] .
Factors reported to affect long-term survival after CWR for local breast cancer recurrence include age at primary treatment, bone involvement, additional metastases, the DFI, the size or diameter of the local recurrence, lymph node involvement and completeness of the resection [5, 12, 19, 20] . In our study, the only factor significantly associated with better survival was resection extended to adjacent intrathoracic structures, which probably indicated a wider free margin. These results and our higher long-term survival rate compared with those reported in the recent literature (Table 5 ) [4] [5] [6] [16] [17] [18] [19] may be ascribable to two factors. First, we excluded patients with detectable metastases at the time of the local recurrence. Second, we consistently attempted to perform en-bloc R0 resection, and therefore we excluded patients whose preoperative investigations indicated that complete resection of the local recurrence was not feasible. In the study by Downey et al. [4] , 8 (25%) patients underwent incomplete CWR (R1) and 12 (32%) had distant metastases other than loco-regional lymph nodes, explaining the lower 5-year survival rate of 18% overall and 35% in the sub-group without distant metastases. Similarly, Henderson et al. [19] had a 26% rate of incomplete resection and a 5-year survival rate of 24%. Unlike these two groups, and similarly to Van der Pol et al. [16] , we did not consider full-thickness CWR for palliative indications, as we felt the risk/benefit ratio was unfavourable in patients with distant metastases or incomplete resection.
However, our policy is debatable, and we acknowledge that CWR may have a role as a palliative procedure. Palliative CWR has been advocated as a means of relieving pain and eliminating skin ulcers associated with bleeding, infection and a malodorous discharge [4, 5, 20] . These effects of palliative CWR may substantially improve the patient's quality of life. Given the absence of operative mortality and the acceptable rate of morbidity in our study, we plan to discuss the appropriateness of palliative fullthickness CWR with our oncologists. Surgery should be weighed against other, less-aggressive treatments such as radiation therapy. However, full-thickness CWR should be viewed as part of the therapeutic armamentarium for local breast cancer recurrences, even in patients with metastases.
The limitations of our study include the single-centre retrospective design, small number of highly selected patients and short follow-up. However, despite these limitations, we found that en-bloc full-thickness CWR extended as needed to adjacent structures provided an excellent long-term survival with an acceptable morbidity rate in patients with locally recurrent breast cancer and no detectable distant metastases.
In conclusion, extensive full-thickness CWR should be considered the treatment of choice in patients with isolated local breast cancer recurrences. Studies are needed to assess the role 
